Development Level

Tbio 2 | 10,625
Tchem 1 | 1,890

IMPC Term

decreased monocyte cell number 2 | 28
abnormal cranium morphology 1 | 32
abnormal head morphology 1 | 10
decreased circulating calcium ... 1 | 33
preweaning lethality, complete... 1 | 633

Disease

Bone Resorption 2 | 7
Brachydactyly 2 | 52
Cancer 2 | 2,346
Hypercalcemia 2 | 37
Hyperparathyroidism 2 | 43
Hypoparathyroidism 2 | 29
Hypophosphatemia 2 | 31
Kidney failure 2 | 39
Leydig cell tumor 2 | 9
Metaphyseal dysplasia 2 | 11
Osteoporosis 2 | 257
Parathyroid Adenoma 2 | 11
Pseudohypoparathyroidism 2 | 17
astrocytic glioma 2 | 2,241
ovarian cancer 2 | 8,484
pancreatic cancer 2 | 2,300
Achondroplasia 1 | 20
Adenoma 1 | 165
Anemia 1 | 252
Arthritis 1 | 248
Atherosclerosis 1 | 275
Attention deficit hyperactivity disorder 1 | 156
BRACHYDACTYLY, TYPE E2 1 | 1
Bone Diseases, Endocrine 1 | 2
Brachydactyly syndrome type E 1 | 2
Breast cancer 1 | 3,094
Cachexia 1 | 10
Calcinosis 1 | 62
Congenital Foot Deformity 1 | 4
Congenital Hand Deformities 1 | 8
Coronary artery disease 1 | 240
Goiter 1 | 27
Growth Disorders 1 | 33
Heart disease 1 | 279
Heart failure 1 | 80
Hyperalgesia 1 | 71
Hypercalciuria 1 | 3
Hyperostosis 1 | 16
Hyperparathyroidism, Primary 1 | 1
Hyperparathyroidism, Secondary 1 | 5
Hyperphosphatemia 1 | 32
Hyperphosphatemia (disorder) 1 | 4
Hypersensitivity reaction type II disease 1 | 235
Hypertension 1 | 287
Hypertensive disease 1 | 193
Hyperthyroidism 1 | 50
Hypervitaminosis D 1 | 8
Hypocalcemia 1 | 5
Hypogonadism 1 | 70
Hypoparathyroidism familial isolated 1 | 3
Hypothyroidism 1 | 89
IGA Glomerulonephritis 1 | 454
Liver Neoplasms, Experimental 1 | 48
Liver disease 1 | 219
Lung diseases 1 | 48
Lytic lesion 1 | 7
Mammary Neoplasms 1 | 410
Metabolic acidosis 1 | 49
Metabolic syndrome X 1 | 155
Multiple Endocrine Neoplasia Type 1 1 | 30
Multiple Sclerosis 1 | 498
Nephrolithiasis 1 | 30
Neuroendocrine Tumors 1 | 10
Neuromyelitis optica 1 | 20
Ollier disease 1 | 15
Optic disk drusen 1 | 5
Optic neuritis 1 | 9
Osteitis fibrosa 1 | 6
Osteoarthritis 1 | 96
Osteogenesis imperfecta 1 | 34
Osteomalacia 1 | 28
Osteonecrosis 1 | 25
Osteoporosis, Postmenopausal 1 | 7
Osteosclerosis 1 | 10
Pancreatic Neoplasm 1 | 79
Pancreatitis 1 | 97
Pancreatitis, Alcoholic 1 | 1
Prostatic Neoplasms 1 | 471
Proteinuria 1 | 63
Renal osteodystrophy 1 | 10
Renal tubular acidosis 1 | 14
Rickets 1 | 42
Spontaneous abortion 1 | 108
Superior Vena Cava Syndrome 1 | 1
Thyrotoxicosis 1 | 38
Uremia 1 | 19
acute myeloid leukemia 1 | 780
chronic rhinosinusitis 1 | 512
cystic fibrosis and chronic rhinosinusitis 1 | 213
diabetes mellitus 1 | 1,663
fibroadenoma 1 | 557
inflammatory breast cancer 1 | 404
lung adenocarcinoma 1 | 2,713
non-small cell lung cancer 1 | 2,798
non-small cell lung carcinoma 1 | 413
oligodendroglioma 1 | 2,849
pilocytic astrocytoma 1 | 3,086
primary pancreatic ductal adenocarcinoma 1 | 1,271
sarcoidosis 1 | 358
uncontrolled asthma 1 | 67

Tissue

Digestive Tract 3 | 18,473
Endocrine System 3 | 18,512
Female tissues 3 | 18,647
Liver and Pancreas 3 | 18,136
Nervous System 3 | 18,561
Urinary Tract 3 | 18,444
Blood and immune system 2 | 17,995
Cardiovascular System 2 | 17,958
Male tissues 2 | 17,969
Respiratory system 2 | 17,484
Skin and soft tissues 2 | 18,115

Target Family

Non-IDG 3 | 11,971

Grant Application

5R01DK054308-04 3 | 3
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Parathyroid hormone-related protein PTHLH Tchem Non-IDG -3.25775 2090.5 248
Parathyroid hormone PTH Tbio Non-IDG -4.29465 20357.7 972
Cyclin-D1-binding protein 1 CCNDBP1 Tbio Non-IDG -1.47409 34.9 171